Cargando…
Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1β expression
Bone diseases such as osteoporosis and periodontitis are induced by excessive osteoclastic activity, which is closely associated with inflammation. Benzydamine (BA) has been used as a cytokine-suppressive or non-steroidal anti-inflammatory drug that inhibits the production of pro-inflammatory cytoki...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049613/ https://www.ncbi.nlm.nih.gov/pubmed/32140392 http://dx.doi.org/10.1016/j.apsb.2019.11.004 |